GSK1399686

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Colitis, UlcerativeInflammatory Bowel Diseases

Phase 1

A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686

CompletedNCT00721812

GlaxoSmithKlineInflammatory Bowel Diseases

Start: 2008-09-25End: 2009-05-27Updated: 2017-07-07

Phase 2

Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis

CompletedNCT01036022

GlaxoSmithKlineColitis, Ulcerative

Start: 2009-09-15End: 2013-01-10Updated: 2017-12-18